{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,7]],"date-time":"2022-08-07T06:24:51Z","timestamp":1659853491105},"reference-count":30,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/mmy\/myx159","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T07:09:12Z","timestamp":1512544152000},"source":"Crossref","is-referenced-by-count":2,"title":["In vitro interactions of azoles and echinocandins against clinical strains of Aspergillus flavus"],"prefix":"10.1093","author":[{"given":"Laura Bedin","family":"Denardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francielli Pantella Kunz","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Hoch","family":"Dalla-Lana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janio Morais","family":"Santurio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9gis Adriel","family":"Zanette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney Hartz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"key\n\t\t\t\t20171227103518_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1086\/513943","article-title":"Invasive aspergillosis","volume":"26","year":"1998","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171227103518_bib2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/mic.0.2007\/007641-0","article-title":"Aspergillus flavus: human pathogen, allergen and mycotoxin producer","volume":"153","year":"2007","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171227103518_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171227103518_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171227103518_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171227103518_bib6","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","year":"2008","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20171227103518_bib7","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/AAC.00637-15","article-title":"A novel Y319H substitution in cyp51C associated with azole resistance in Aspergillus flavus","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib8","first-page":"355","article-title":"Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis","volume":"115","year":"2006","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171227103518_bib9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11908-011-0216-6","article-title":"Current role of echinocandins in the management of invasive aspergillosis","volume":"13","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"key\n\t\t\t\t20171227103518_bib10","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.ijid.2011.10.004","article-title":"The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review","volume":"16","year":"2012","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20171227103518_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/13543784.10.2.269","article-title":"Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors","volume":"10","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20171227103518_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1055\/s-2008-1063858","article-title":"Update on azole antifungals","volume":"29","year":"2008","journal-title":"Semin Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171227103518_bib13","first-page":"315","article-title":"Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics","volume-title":"PCR Protocols: A Guide to Methods and Applications","year":"1990"},{"key":"key\n\t\t\t\t20171227103518_bib14","first-page":"3","article-title":"Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds","volume":"9","year":"2015","journal-title":"EUCAST E.DEF"},{"key":"key\n\t\t\t\t20171227103518_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/mmy\/myt008","article-title":"An opportunistic human pathogen on the fly: strains of Aspergillus flavus vary in virulence in Drosophila melanogaster","volume":"52","year":"2014","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171227103518_bib17","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1111\/j.1439-0507.2010.01996.x","article-title":"In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs","volume":"54","year":"2011","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20171227103518_bib18","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/AAC.01902-12","article-title":"In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother."},{"key":"key\n\t\t\t\t20171227103518_bib19","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.01155-09","article-title":"In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method","volume":"47","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171227103518_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.diagmicrobio.2005.01.001","article-title":"Increased frequency of non-fumigatus Aspergillus species in amphotericin B or triazole-pre-exposed cancer patients with positive cultures for aspergilli","volume":"52","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171227103518_bib21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.01543-08","article-title":"Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds","volume":"53","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/pbc.20302","article-title":"Successful antifungal combination therapy with voriconazole and caspofungin","volume":"44","year":"2005","journal-title":"Pediatr Blood Cancer."},{"key":"key\n\t\t\t\t20171227103518_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/13693780500271772","article-title":"Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin","volume":"43","year":"2005","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20171227103518_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11046-011-9507-6","article-title":"Combined therapy of voriconazole and anidulafungin in murine infections by Aspergillus flavus","volume":"173","year":"2012","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20171227103518_bib25","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/AAC.49.8.3572-3574.2005","article-title":"In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus and Fusarium spp","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/AAC.47.4.1416-1418.2003","article-title":"In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/jac\/dkg242","article-title":"Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus","volume":"51","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib28","article-title":"In vitro and in vivo interaction of posaconazole (POS) and caspofungin (CSP) against Aspergillus [abstract M-990]","volume-title":"Program and abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy","year":"2003"},{"key":"key\n\t\t\t\t20171227103518_bib29","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.04469-14","article-title":"The strength of synergistic interaction between posaconazole and caspofungin depends on the underlying azole resistance mechanism of Aspergillus fumigatus","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171227103518_bib30","first-page":"457","article-title":"Synergistic effect of anidulafungin combined with posaconazole in experimental aspergillosis","volume":"55","year":"2017","journal-title":"Med Mycol"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myx159\/23121318\/myx159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T10:37:39Z","timestamp":1514371059000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/mmy\/advance-article\/doi\/10.1093\/mmy\/myx159\/4780440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1093\/mmy\/myx159","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,27]]}}}